2022: Clovis files for bankruptcy, will keep operating and plans to sell pipeline asset to Novartis

Attachments

?utm_medium=email&utm_campaign=1614%20-%20Versant%20NEA%20spin%20out%20antibody-focused%20oncology%20startup%20Vertex%20preps%20first%20mRNA%20program%20for%20the%20clinic%20Basic&utm_content=1614%20-%20Versant%20NEA%20spin%20out%20antibody-focused%20oncology%20startup%20Vertex%20preps%20first%20mRNA%20program%20for%20the%20clinic%20Basic+CID_111b605a8735534d2baf6b215d0a7330&utm_source=ENDPOINTS%20emails&utm_term=Clovis%20files%20for%20bankruptcy%20will%20keep%20operating%20and%20plans%20to%20sell%20pipeline%20asset%20to%20Novartis